PJSC Pharmsynthez announced earnings results for the first quarter of 2016. For the quarter, the company's net losses reduced by 43% year-on-year to RUB 37.004 million. The company's revenue fell 37.3% to RUB 54.992 million. Pretax losses fell 38.7% to RUB 45.113 million.